Status:
COMPLETED
Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer
Lead Sponsor:
University Hospitals of North Midlands NHS Trust
Conditions:
Prostate Carcinoma
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Purpose of the study 1. To assess whether offering visual information to patients with prostate cancer prior to receiving RT increases the participant's compliance. 2. To assess whether increased com...
Detailed Description
The Oncology Department at the Royal Stoke University Hospital is a state of the art facility. It has radiotherapy (RT) facilities such as IMRT and rapid arc, leading the way in RT planning and delive...
Eligibility Criteria
Inclusion
- Patients with the histological diagnosis of prostate cancer due to receive radical RT.
- Patients with prostate cancer deemed fit enough to complete a course of radical RT to their prostate area.
- Patients able to give informed consent.
Exclusion
- The only exclusion criteria is for participants unable to understand the study aims and therefore unable to give informed consent.
Key Trial Info
Start Date :
October 8 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT03326440
Start Date
October 8 2015
End Date
May 31 2018
Last Update
October 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of North Midlands, Royal Stoke University Hospital, City General Site, Newcaslte Road
Stoke-on-Trent, Staffordshire, United Kingdom, ST4 6QG